Suspicious papanicolaou
smears (pap smears) and vaginal haemorrhage were reported as frequent
post marketing events by patients with multiple sclerosis using
Copaxone.
Post marketing adverse event reporting which may or may not indicate
a causal relationship with Copaxone ® has reported rheumatoid
arthritis while using glatiramer acetate.
